Etienne Garin Selected Research

Microspheres (Microsphere)

1/2022	A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study.
1/2022	Evaluating the Effectiveness of Yttrium-90 Glass Microspheres in the Treatment of Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, and Metastatic Colorectal Cancer in Practice: Protocol for the Prospective PROACTIF Phase IV Registry Study in France.
11/2021	Selective Internal Radiation Combined with Chemotherapy Maintains the Quality of Life in Intrahepatic Cholangiocarcinomas.
1/2021	Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial.
6/2020	Personalised Dosimetry in Radioembolisation for HCC: Impact on Clinical Outcome and on Trial Design.
1/2020	Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.
7/2019	Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group.
5/2019	90Y-Loaded Microsphere SIRT of HCC Patients With Portal Vein Thrombosis: High Clinical Impact of 99mTc-MAA SPECT/CT-Based Dosimetry.
1/2019	Yttrium-90 glass microspheres radioembolization (RE) for biliary tract cancer: a large single-center experience.
1/2018	Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Etienne Garin Research Topics

Disease

37	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 10/2004
23	Neoplasms (Cancer) 01/2022 - 03/2008
8	Cholangiocarcinoma 01/2022 - 11/2015
6	Thrombosis (Thrombus) 05/2019 - 01/2010
5	Neoplasm Metastasis (Metastasis) 12/2021 - 03/2010
5	Liver Neoplasms (Liver Cancer) 05/2016 - 02/2012
4	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 02/2017
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2019 - 11/2015
2	Hypertrophy 01/2018 - 08/2013
2	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2011 - 06/2011
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 08/2011 - 12/2010
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Ascites 01/2021
1	Jaundice (Icterus) 01/2021
1	Liver Failure 01/2021
1	Rectal Diseases (Rectal Disease) 09/2020
1	Rheumatoid Arthritis 01/2019
1	Ischemic Stroke 02/2017
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2017
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2017
1	Neutropenia 01/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Fibrosis (Cirrhosis) 03/2016
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2016
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2014
1	Hepatoblastoma 09/2013
1	Ulcer 05/2012
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2011
1	Respiratory Insufficiency (Respiratory Failure) 06/2011
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 12/2010
1	Parkinson Disease (Parkinson's Disease) 08/2010
1	Disease Progression 06/2009
1	Breast Neoplasms (Breast Cancer) 12/2006
1	Residual Neoplasm 12/2006
1	Experimental Liver Neoplasms 10/2004

Drug/Important Bio-Agent (IBA)

11	SirtuinsIBA 01/2022 - 11/2015
11	Ethiodized Oil (Ethiodol)FDA Link 07/2019 - 10/2004
9	Yttrium-90IBA 01/2022 - 03/2015
7	AlbuminsIBA 01/2021 - 12/2011
6	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 09/2020 - 12/2006
6	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 09/2013
4	fluoromethylcholineIBA 01/2019 - 02/2017
2	YttriumIBA 01/2022 - 01/2020
2	Radioisotopes (Radionuclides)IBA 01/2019 - 01/2010
2	RadiopharmaceuticalsIBA 01/2019 - 03/2011
2	Choline (Choline Chloride)IBA 05/2018 - 02/2017
2	Rhenium-188IBA 01/2012 - 03/2011
1	Alanine Transaminase (SGPT)IBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	Human Serum Albumin FDA LinkGeneric 01/2020
1	Technetium (Technetium 99m)IBA 01/2020
1	macro aggregates of albuminIBA 01/2018
1	mahuang-tangIBA 01/2018
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2017
1	Coloring Agents (Dyes)IBA 12/2015
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2015
1	Gemcitabine FDA Link 12/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2015
1	RheniumIBA 09/2013
1	stearic acid (magnesium stearate)FDA LinkGeneric 03/2012
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2011
1	Pharmaceutical PreparationsIBA 06/2011
1	LipidsIBA 03/2011
1	NanocapsulesIBA 03/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2010
1	Rituximab (Mabthera)FDA Link 12/2010
1	Prednisone (Sone)FDA LinkGeneric 12/2010
1	Vincristine (Oncovin)FDA LinkGeneric 12/2010
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2010
1	Tamoxifen FDA LinkGeneric 10/2010
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2010
1	Somatostatin Receptors (Somatostatin Receptor)IBA 06/2009
1	Iodine-131IBA 09/2008
1	Therapeutic UsesIBA 01/2007
1	Cisplatin (Platino)FDA LinkGeneric 03/2006
1	LUFIBA 06/2005
1	EmulsionsIBA 06/2005
1	Iodized OilIBA 06/2005

Therapy/Procedure

27	Microspheres (Microsphere) 01/2022 - 01/2010
18	Radiotherapy 01/2022 - 10/2004
10	Therapeutics 01/2022 - 01/2007
8	Drug Therapy (Chemotherapy) 12/2021 - 12/2006
4	Intra-Arterial Injections 01/2010 - 03/2006
2	Radioimmunotherapy 01/2017 - 02/2013
2	Deep Brain Stimulation 12/2010 - 08/2010
1	Contraindications 01/2021
1	Immunotherapy 08/2020
1	Induction Chemotherapy 01/2017
1	Transplantation 01/2017
1	Palliative Care (Palliative Therapy) 09/2013
1	Aftercare (After-Treatment) 10/2010
1	Neoadjuvant Therapy 12/2006